ARTICLE | Clinical News
Omiganan: Phase III start
March 17, 2008 7:00 AM UTC
Later this year, Cutanea will start a Phase III trial of topical Omiganan. The company has exclusive rights to Omiganan for dermatological applications from Migenix. ...
Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Later this year, Cutanea will start a Phase III trial of topical Omiganan. The company has exclusive rights to Omiganan for dermatological applications from Migenix. ...